GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) » Definitions » 3-Year EPS without NRI Growth Rate

Dr. Lal PathLabs (NSE:LALPATHLAB) 3-Year EPS without NRI Growth Rate : 12.00% (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs 3-Year EPS without NRI Growth Rate?

Dr. Lal PathLabs's EPS without NRI for the three months ended in Mar. 2025 was ₹18.57.

During the past 12 months, Dr. Lal PathLabs's average EPS without NRI Growth Rate was 35.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 12.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 12.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 14.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Dr. Lal PathLabs was 39.60% per year. The lowest was 2.80% per year. And the median was 19.30% per year.


Competitive Comparison of Dr. Lal PathLabs's 3-Year EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr. Lal PathLabs's 3-Year EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's 3-Year EPS without NRI Growth Rate falls into.


;
;

Dr. Lal PathLabs 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Dr. Lal PathLabs  (NSE:LALPATHLAB) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Dr. Lal PathLabs 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr. Lal PathLabs Business Description

Traded in Other Exchanges
Address
12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs Headlines

No Headlines